Volume 16, issue 3, mai-juin 2010

Éditorial

Use of signatures to identify new therapies: an useful strategy in neoplastic blood disorders (p.183-4)
François Sigaux
Free Access

Actualités cliniques

Actualités cliniques (p.185-94)

Free Access

Revue

Will endothelial progenitor cells represent a cell therapy product for the treatment of cardiovascular diseases? (p.198-207)
David M Smadja, Ivan Bieche, Martine Aiach, Pascale Gaussem
Free Access

Congenital dyserythropoietic anemias (p.208-21)
Loïc Garçon, Jean Delaunay
Free Access

Haemovigilance of the transfused patient (p.222-7)
Jean-Yves Py
Free Access

Blood transfusion in the hemopathies at the end of the lifetime: ethical and organisational aspects (p.228-34)
Dominique Jaulmes, Joël Ceccaldi, Philippe Colombat
Free Access

Mini-revue

Regulation mechanisms controlling fetal hemoglobin expression (p.235-43)
Dominique Labie
Free Access

Les jeunes hématologistes ont la parole

Refractory or relapsed Hodgkin lymphoma: which treatment for which patients? (p.244-52)
Tereza Coman
Free Access

Hodgkin lymphoma pathogenesis (p.253-9)
Géraldine Salmeron
Free Access

Note technique

Evaluation of the eosin-5-maleimide flow cytometric test for the diagnosis of hereditary spherocytosis (p.261-3)
Marie Loosveld, Isabelle Arnoux
Free Access